Elan Pharmaceutical has completed the sale of its four pain products and related assets to aaiPharma Inc for $101.8m.(€83.6m).

Anglo-Irish continued to power ahead on the Irish Stock Exchange on Wednesday closing at €10.40.

Pharmaceutical company Elan is to sell four main products and related assets to aaiPharma Inc for $100m (€85m), subject to regulatory approval.